166 related articles for article (PubMed ID: 37176127)
1. Kallikrein-Related Peptidase 12 (KLK12) in Breast Cancer as a Favorable Prognostic Marker.
Sato A; Takagi K; Yoshimura A; Tsukamoto W; Yamaguchi-Tanaka M; Miki Y; Ebata A; Miyashita M; Suzuki T
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176127
[TBL] [Abstract][Full Text] [Related]
2. Human kallikrein-related peptidase 12: antibody generation and immunohistochemical localization in prostatic tissues.
Memari N; Diamandis EP; Earle T; Campbell A; Van Dekken H; Van der Kwast TH
Prostate; 2007 Sep; 67(13):1465-74. PubMed ID: 17654496
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of human kallikrein 12 gene expression in gastric cancer.
Zhao EH; Shen ZY; Liu H; Jin X; Cao H
World J Gastroenterol; 2012 Dec; 18(45):6597-604. PubMed ID: 23236234
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of kallikrein-related peptidase 12 (KLK12) mRNA expression in triple-negative breast cancer patients.
Gong W; Liu Y; Preis S; Geng X; Petit-Courty A; Kiechle M; Muckenhuber A; Dreyer T; Dorn J; Courty Y; Magdolen V
Mol Med; 2020 Feb; 26(1):19. PubMed ID: 32028882
[TBL] [Abstract][Full Text] [Related]
5. Human kallikrein-related peptidase 12 (KLK12) splice variants expression in breast cancer and their clinical impact.
Talieri M; Devetzi M; Scorilas A; Pappa E; Tsapralis N; Missitzis I; Ardavanis A
Tumour Biol; 2012 Aug; 33(4):1075-84. PubMed ID: 22351561
[TBL] [Abstract][Full Text] [Related]
6. Kallikrein-related peptidase 12 hydrolyzes matricellular proteins of the CCN family and modifies interactions of CCN1 and CCN5 with growth factors.
Guillon-Munos A; Oikonomopoulou K; Michel N; Smith CR; Petit-Courty A; Canepa S; Reverdiau P; Heuzé-Vourc'h N; Diamandis EP; Courty Y
J Biol Chem; 2011 Jul; 286(29):25505-18. PubMed ID: 21628462
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of kallikrein-related peptidase transcript levels in prostate cancer.
Lehto TK; Kovanen RM; Lintula S; Malén A; Stürenberg C; Erickson A; Pulkka OP; Stenman UH; Diamandis EP; Rannikko A; Mirtti T; Koistinen H
Int J Cancer; 2023 Aug; 153(4):867-881. PubMed ID: 37139608
[TBL] [Abstract][Full Text] [Related]
8. Kallikrein 12 downregulation reduces AGS gastric cancer cell proliferation and migration.
Li XS; He XL
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706634
[TBL] [Abstract][Full Text] [Related]
9. Gene Expression of Kallikreins in Breast Cancer Cell Lines.
Watrowski R; Castillo-Tong DC; Obermayr E; Zeillinger R
Anticancer Res; 2020 May; 40(5):2487-2495. PubMed ID: 32366393
[TBL] [Abstract][Full Text] [Related]
10. Enzymatic properties of human kallikrein-related peptidase 12 (KLK12).
Memari N; Jiang W; Diamandis EP; Luo LY
Biol Chem; 2007 Apr; 388(4):427-35. PubMed ID: 17391064
[TBL] [Abstract][Full Text] [Related]
11. Activation profiles of human kallikrein-related peptidases by proteases of the thrombostasis axis.
Yoon H; Blaber SI; Evans DM; Trim J; Juliano MA; Scarisbrick IA; Blaber M
Protein Sci; 2008 Nov; 17(11):1998-2007. PubMed ID: 18697857
[TBL] [Abstract][Full Text] [Related]
12. KLK12 is a novel serine protease and a new member of the human kallikrein gene family-differential expression in breast cancer.
Yousef GM; Magklara A; Diamandis EP
Genomics; 2000 Nov; 69(3):331-41. PubMed ID: 11056051
[TBL] [Abstract][Full Text] [Related]
13. Kallikrein-related peptidases in lung diseases.
Lenga Ma Bonda W; Iochmann S; Magnen M; Courty Y; Reverdiau P
Biol Chem; 2018 Sep; 399(9):959-971. PubMed ID: 29604204
[TBL] [Abstract][Full Text] [Related]
14. Human kallikrein-related peptidase 12 (KLK12) splice variants discriminate benign from cancerous breast tumors.
Papachristopoulou G; Tsapralis N; Michaelidou K; Ardavanis-Loukeris G; Griniatsos I; Scorilas A; Talieri M
Clin Biochem; 2018 Aug; 58():78-85. PubMed ID: 29807016
[TBL] [Abstract][Full Text] [Related]
15. Novel splice variants of the human kallikrein-related peptidases 11 (KLK11) and 12 (KLK12), unraveled by next-generation sequencing technology.
Adamopoulos PG; Kontos CK; Scorilas A
Biol Chem; 2018 Sep; 399(9):1065-1071. PubMed ID: 29874189
[TBL] [Abstract][Full Text] [Related]
16. Kallikrein 12 Regulates Innate Resistance of Murine Macrophages against
Sabir N; Hussain T; Liao Y; Wang J; Song Y; Shahid M; Cheng G; Mangi MH; Yao J; Yang L; Zhao D; Zhou X
Cells; 2019 May; 8(5):. PubMed ID: 31060300
[No Abstract] [Full Text] [Related]
17. Knockdown of KLK12 inhibits viability and induces apoptosis in human colorectal cancer HT-29 cell line.
Li Q; Zhou X; Fang Z; Zhou H
Int J Mol Med; 2019 Nov; 44(5):1667-1676. PubMed ID: 31485623
[TBL] [Abstract][Full Text] [Related]
18. Kallikreins as microRNA targets: an in silico and experimental-based analysis.
Chow TF; Crow M; Earle T; El-Said H; Diamandis EP; Yousef GM
Biol Chem; 2008 Jun; 389(6):731-8. PubMed ID: 18627289
[TBL] [Abstract][Full Text] [Related]
19. Tissue factor pathway inhibitor 2 is a potent kallikrein-related protease 12 inhibitor.
Lavergne M; Guillon-Munos A; Lenga Ma Bonda W; Attucci S; Kryza T; Barascu A; Moreau T; Petit-Courty A; Sizaret D; Courty Y; Iochmann S; Reverdiau P
Biol Chem; 2021 Sep; 402(10):1257-1268. PubMed ID: 33977679
[TBL] [Abstract][Full Text] [Related]
20. Forkhead Box I1 in Breast Carcinoma as a Potent Prognostic Factor.
Onodera Y; Takagi K; Neoi Y; Sato A; Yamaguchi M; Miki Y; Ebata A; Miyashita M; Sasano H; Suzuki T
Acta Histochem Cytochem; 2021 Aug; 54(4):123-130. PubMed ID: 34511651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
